Bubs Australia Ltd
ASX:BUB

Watchlist Manager
Bubs Australia Ltd Logo
Bubs Australia Ltd
ASX:BUB
Watchlist
Price: 0.135 AUD 3.85% Market Closed
Market Cap: AU$120.7m

Bubs Australia Ltd
Investor Relations

Bubs Australia Ltd. is a holding company, which offers organic baby food, goat milk infant formula and fresh dairy products. The company is headquartered in Frenchs Forest, New South Wales and currently employs 35 full-time employees. The firm produces goat dairy products and organic food products for all ages under the Bubs brand. Its products include cow’s milk formula, goats milk formula, organic baby food, cereals, toddler snacks, Vita Bubs, puree, rusks, infant and children's vitamin and mineral supplements. The company also offers children’s vitamin and mineral supplements that are also formulated with goat milk and address immune, bone, digestive and cognitive health concerns parents have for their children. The firm offers goat dairy products and produces goat milk-based formulae for adult everyday use, formulations, and adult immunity support for domestic and export markets. Its products are sold in supermarkets and pharmacies throughout Australia, as well as exported to China, Vietnam, Southeast Asia and the Middle East.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2020
Call Date
Apr 14, 2020
AI Summary
Q3 2020

Record Sales: Bubs Australia delivered record quarterly gross sales of $19.7 million, up 67% from the same period last year and up 36% from the previous quarter.

Strong Infant Formula Growth: Infant formula sales grew 137% year-on-year and 58% quarter-over-quarter, driven by both goat dairy and organic grass-fed product lines.

Profitability & Cash Flow: The business generated a positive operational cash flow of $2.3 million and ended the quarter with strong cash balances of $36.4 million.

COVID-19 Resilience: Bubs saw increased demand across all channels during COVID-19, with minimal supply chain disruption and successful adaptation to new logistics challenges.

Outlook: Management expects continued sales growth into the fourth quarter and beyond, supported by product expansion and key competitive advantages.

Key Financials
Gross Sales
$19.7 million
Infant Formula Sales Growth
137%
Operational Cash Flow
$2.3 million surplus
Cash Balance
$36.4 million
Domestic Sales Revenue Growth
123%
Domestic Share of Gross Sales
62%
China Direct Revenue Growth
more than doubled
China Share of Gross Sales
24%
Earnings Call Recording
Other Earnings Calls
2020

Management

Mr. Reginald Weine B. Bus., C.P.M.
CEO, MD & Director
No Bio Available
Mr. Richard Paine
Chief Operating Officer
No Bio Available
Ms. Aaliyah Nyathi
Interim Chief Financial Officer
No Bio Available
Ms. Vivian Zurlo
Chief Marketing & Innovation Officer
No Bio Available
Mr. Dylan Lu
Managing Director - Greater China
No Bio Available
Mr. James Richard Stephenson C.A., C.M.A., C.P.A., CMA, CMA (Canada), CMA and F
Company Secretary
No Bio Available

Contacts

Address
NEW SOUTH WALES
Frenchs Forest
2-4/6 Tilley Lane
Contacts
+61180028272878.0
www.bubsaustralia.com